ClinicalTrials.gg
Status unknownNCT04115215FRONT STAGEUpdated Jul 2, 2021

Pre-FRONTal Brain STability, Key for Action Against Disability in AGing

An interventional study of Physical exercise (PE) and Transcranial current stimulation (tCS) in Cognitive Impairment and Motoric Cognitive Risk Syndrome, sponsored by Parc Sanitari Pere Virgili. Status unknown at 5 sites in Spain. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2021-07-02.

Sponsored by Parc Sanitari Pere Virgili · Not applicable, Interventional, and Prevention

How we know

The sponsor has not verified this record recently (last verified Jun 2021), so the status shown — last known as Enrolling by invitation — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 162 studies in Cognitive Dysfunction with a site in Spain — 44 open to participants now, 61 under way, 9 of them phase 3. Cognitive Dysfunction · Spain.

Planned enrollment
75th of 127
93 · median 100
Started
2020
with 5 others
No phase
91 of 162
27 open now
Registered
48th of 162
by date

Among the 162 studies in Cognitive Dysfunction with a site in Spain, this one is the 75th largest by planned enrollment of the 127 interventional ones that give a count, is one of 6 that started in 2020, is one of 91 with no phase, and was the 48th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

44 of the 162 studies in Cognitive Dysfunction with a site in Spain are open now. Recruiting first, the newest first:

39 more — sign in →

All 44 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 162 studies in Cognitive Dysfunction with a site in Spain, or all of them as a file.
02

Study summary

Cognitive and mobility impairments are critical contributors to dementia and disability in older adults, and can be caused by neurodegenerative and neurovascular changes at the pre-frontal (PF) brain areas. In a previous technological project funded by ISCiii, the investigators adapted a non-invasive, point-of-care optical methods (fNRIS/fDCS technology) to study PF metabolism and blood flow activation during cognitive and motor tasks, in older adults with and without cognitive impairment. These methods are sensitive to change after physical exercise (PE) and after selectively and safely stimulating PF areas with electrical transcranial direct current stimulation (tCS). PE and tCS have shown benefits for cognition and mobility in the elderly, but their prolonged effect on PF hemodynamic activation has not been studied. Understanding the specific action of these interventions on the brain, and their clinical cognitive and motor impact, is key to fine-tune appropriate treatment strategies.

The FRONT STAGE project aims to compare, through a 3 arms single-blind randomized clinical trial, the impact of a 10 weeks, 1 hour/week program of PE (arm 1) Vs PE+tCS (arm 2) and Vs a control group (arm 3, healthy aging sessions and control of cardiovascular risk factors). The PE program is already implemented in primary care, as part of another previous project of the investigators' research group. Outcomes will include the optical measurement of PF metabolism and blood flow and clinical measures of cognitive and physical function. Front STAGE project will recruit 93 older adults with cognitive impairment and slow gait, but without dementia or disability in the activities of daily living (N=31 per arm). They will receive a comprehensive geriatric assessment at baseline, together with the optical, cognitive and physical measures, and will be follow-up at 3 and 6 months. Weekly physical activity through accelerometry will be controlled in analyses.

FRONT STAGE project centered on aging and the prevention of dementia and disability, will provide, translationally, more evidence to support and enlarge the clinical application of these interventions, and will contribute to foster further research in this field.

03

Conditions studied

  • Cognitive Impairment
  • Motoric Cognitive Risk Syndrome

Keywords

  • Older adults
  • Cognitive impairment
  • Motoric Cognitive Risk Syndrome
  • Physical disfunction
  • Multi-component physical exercise program
  • Transcranial electrical stimulation
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. older adults (65 years or older)
  2. with Motoric Cognitive Risk Syndrome
  3. characterized by impaired cognition (which in our case will be confirmed with a Spanish version of the (MOCA), score between 26 and 21)
  4. mobility impairment (measured as slow gait speed\<0.8 m/s)
  5. without diagnosed clinical neurological or psychiatric diseases
  6. with a preserved functional status for the activities of daily living
  7. who can walk without help from third parties

Exclusion criteria

Exclusion Criteria:

  1. a diagnosis of dementia
  2. advanced/terminal disease (\<1 year)
  3. to exercise and tCS
  4. unwilling to give
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
93 participants (estimated)

Study arms

  • Experimental
    Arm 1

    Physical exercise (PE)

    Behavioral: Physical exercise (PE)

  • Experimental
    Arm 2

    Transcranial current stimulation (tCS)

    Behavioral: Physical exercise (PE) · Device: Transcranial current stimulation (tCS)

  • Active comparator
    Control

    Educational sessions on healthy aging

    Other: Control

Interventions

  • BehavioralPhysical exercise (PE)

    This arm includes 10 sessions of multi-component exercise sessions (including aerobic, resistance, flexibility, dual-tasking) of 1 hour/week of functional group exercise, directed to foster empowerment for subsequent continuation of exercise in community-dwelling older adults referred by primary care to a geriatrician and an expert physical therapist. Participants will receive a leaflet with instructions to perform five strength-based exercises and instructors will recommend participants to perform the exercises and walk at least 15 minutes daily.

  • DeviceTranscranial current stimulation (tCS)

    This arm includes 1 application/week for 10 weeks during PE, through an adapted commercial helmet. Transcranial current stimulation (tCS) is a neural stimulation technique based on electrical stimulation of selected parts of the brain with direct or alternated electrical current (tDCS or tACS) of very low intensity of 1,5 milliamps (mA), using one or more electrodes placed on the skull. tCS is non-invasive (no surgical procedures) and it is painless, as applied in the proposed protocols.

  • OtherControl

    Participants of similar profile, randomized to the control group, will undergo weekly 30 minutes educational sessions on healthy aging, including relevant aspects of nutrition, self-care, physical activity, plus measurement of blood pressure, heart rate and peripheral oxygen Hb saturation. These participants will be offered to join the PE program after the 6-months follow-up (end of the study).

06

What researchers measure

Primary outcomes

  1. Changes in hemoglobin oxygenation during functional tasks, as measured using fNIRS+fDCS optical techniques.

    Our primary outcome will be prefrontal hemoglobin oxygenation during a) cognitive tests, such as phonetic verbal fluency and calculations (2-forward and 3-backward counting), b) normal gait, c) dual task (walking while counting). All the measures will be controlled for extra-cerebral and systemic contributions due to variations in heart-rate, oxygen saturation, respiration rate and end-tidal carbondioxide. Various measures such as those derived from accelerometers to account for potential motion artifacts will be also utilized, followed by a multi-subject analysis.

    Time frame: Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

Secondary outcomes

  1. Cognitive executive function tests - Phonetic Verbal Fluency

    Phonetic verbal fluency will be measured by scoring total number of words (not repeated) per unit of time, with higher rates revealing better performance.

    Time frame: Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  2. Rey Auditory Verbal Learning Test (RAVLT)

    Rey Auditory Verbal Learning Test (RAVLT) is a validated neuropsychological test used to assess verbal memory function.

    Time frame: Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  3. Cognitive executive function tests - SDMT

    The symbol-digit modalities test (SDMT) is a symbol substitution neuropsychological test that examines a person's attention and speed of processing. Higher scores will indicate better performance.

    Time frame: Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  4. Physical function

    The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. It has been used as a predictive tool for possible disability and can aid in the monitoring of function in older people. The scores range from 0 (worst performance) to 12 (best performance), aggregated from the different subtests.

    Time frame: Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  5. Motor function

    "Dual task" measure: cost of gait speed reduction when a cognitive task (verbal fluency) is associated during gait, compared to gait alone.

    Time frame: Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  6. Cognitive executive function tests - Digit span

    The digit span is a widely used neuropsychological test to assess attention and working memory.

    Time frame: Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  7. Cognitive executive function tests - Trail Making Test

    Trail Making Test (TMT A and B) will be perform to assess executive function (attention).

    Time frame: Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

Other outcomes

  1. Spatial temporal parameters of gait

    Step length, width and cadence; using the portable 4 meters Protokinetics Zeno computerized carpet.

    Time frame: Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  2. Total time of daily physical activity

    ActivPal devices will be applied for 7 consecutive days to monitor physical activity outside and between exercise sessions, and also in the control group, in order to subsequently adjust the analyses for the activity performed out of the exercise sessions.

    Time frame: 7 consecutive days (arms 2 & 3) just after the start of the intervention.

  3. Clinical comorbidity

    The Charlson Comorbidity Index is a method of categorizing comorbidities of patients based on the International Classification of Diseases (ICD) diagnosis codes found in administrative data, such as hospital abstracts data. Each comorbidity category has an associated weight (from 1 to 6), based on the adjusted risk of mortality or resource use, and the sum of all the weights results in a single comorbidity score for a patient. A score of zero indicates that no comorbidities were found. The higher the score, the more likely the predicted outcome will result in mortality or higher resource use.

    Time frame: Baseline.

  4. Nutritional status

    The Mini Nutritional Assessment Short Form (MNA®-SF) is an effective tool to help identify patients who are malnourished or at risk of malnutrition. Scores range from: 12-14 points, Normal nutritional status; 8-11 points At risk of malnutrition; 0-7 points Malnourished.

    Time frame: Baseline.

  5. Demographics

    Age, gender, education, former profession, marital status, living situation and physical barriers, presence of a valid caregiver.

    Time frame: Baseline.

  6. Self-reported quality of life

    EuroQol-5D is a standardized instrument for measuring generic health status. It has been widely used in population health surveys, clinical studies, economic evaluation and in routine outcome measurement in the delivery of operational healthcare. This instrument is designed for self-completion and as such captures information directly from the respondent, thereby generating data that conforms with the general requirement of all Patient Reported Outcome (PRO) measures. Total score will be used, with higher scores revealing higher quality of life.

    Time frame: Baseline

  7. Body Mass Index

    Weight \& Height will be collected and computed to obtain Body Mass Index.

    Time frame: Baseline

  8. Depressive symptoms

    The Yesavage GDS-15 items assesses depressive symptoms. The scale consists of 15 yes/no questions. Each question is scored as either 0 or 1 points. The following general cutoff may be used to qualify the severity of depressive symptoms: normal 0-4, \>=5 possible depression.

    Time frame: Baseline

  9. Quality of sleep

    Total score of the Jenkins questionnaire will be used to estimate quality of sleep. This questionnaire consists of 4 items rated on a 6-point scale. The 4 items ask how frequently during the previous 4 weeks the respondent experienced difficulty falling asleep, difficulty staying asleep, waking up several times per night, and waking up feeling tired and worn out after the usual amount of sleep. A dichotomous index is computed and coded as 1 if the respondents reported that any of the above sleep disturbances occurred 15 or more nights during the previous 4 weeks or as 0, if not. The selection of 15 nights as the cut-off point for sleep disturbance was based on criteria from the DSM-IV-TR, which stipulate that difficulty maintaining/initiating sleep or non-restorative sleep should be present for 3 or more nights per week for at least 1 month. A similar cut-off point for sleep disturbance was used in previous studies.

    Time frame: Baseline

  10. Drugs

    Total number of drugs prescribed.

    Time frame: Baseline

  11. Hypertension

    Diagnosis of hypertension (yes / no) will be collected as a cardiovascular risk factor.

    Time frame: Baseline

  12. Cholesterol

    High cholesterol (yes / no) will be collected as a cardiovascular risk factor.

    Time frame: Baseline

07

Study locations

5 sites
  • The Institute of Photonic Sciences (ICFO)
    Castelldefels, Barcelona 08860, Spain
  • Hospital Universitario La Ribera
    Alzira, Valencia 46600, Spain
  • Institut Català de la Salut
    Barcelona, 08004, Spain
  • Parc Sanitari Pere Virgili
    Barcelona, 08023, Spain
  • Fundació Ictus
    Barcelona, 08036, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2020 (actual). Primary completion is estimated for Mar 2023, 36 months after the start.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 36 months is above that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2019
First posted
Oct 3, 2019
StartActual
Mar 23, 2020
Primary completionEst.
Mar 23, 2023
CompletionEst.
Mar 23, 2023
Last update
Jul 2, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04115215
Lead sponsor
Parc Sanitari Pere Virgili
Collaborators
Institute for Photonic Sciences - ICFO, Hospital de la Ribera, Fundacio Ictus Malaltia Vascular, Institut Català de la Salut, Vall d'Hebron Research Institute (sponsor)
Responsible party
Sponsor
First posted
Oct 3, 2019
Start date
Mar 23, 2020
Primary completion
Mar 23, 2023 (estimated)
Completion
Mar 23, 2023 (estimated)
Last update
Jul 2, 2021

Study contacts

Marco Inzitari, PhD
principal investigator · Parc Sanitari Pere Virgili - Vall d'Hebron Institute of Research

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion